The increasing popularity of herbal and dietary supplements has led to an alarming trend : a rise in hospitalizations due to ...

BASKING RIDGE, N.J., November 13, 2024--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) will highlight new clinical research and ...

Abbisko announces positive results from phase 3 MANEUVER study of pimicotinib to treat tenosynovial giant cell tumour: Shanghai Wednesday, November 13, 2024, 18:00 Hrs [IST] Abbis ...

Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's Third Quarter 2024 Results Conference Call. At ...

†Data from lapatanib-treated patients with metastatic breast cancer [43,93]. ‡Data from pazopanib-treated patients with renal cell carcinoma [31]. §This is a definition of a possible Hy's law ...

The FDA slapped a boxed warning on Turalio after Daiichi saw liver toxicity in phase 3. There was no evidence of cholestatic ...

1 School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China 2 School of Traditional Chinese Medicine Health Preservation, Guizhou University of Traditional Chinese ...

No cases of hepatotoxicity or visual disturbances were observed. Additionally, there were no clinically significant treatment ...

Notably, the study also showed that treatment with pimicotinib provided statistically significant and clinically meaningful improvements in secondary endpoints associated with important patient ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

Merck KGaA (MKGAY.PK), a German science and technology major, announced that the Phase III MANEUVER trial of pimicotinib, an ...